Showing results (121-130 of 150) with videos related to
Sort By:
Pageof 15
Annals of Surgical Oncology|April 21, 2019
Defining the Role of Lymphadenectomy for Pancreatic Neuroendocrine Tumors: An Eight-Institution Study of 695 Patients from the US Neuroendocrine Tumor Study GroupAlexandra G Lopez-Aguiar, Mohammad Y Zaidi, Eliza W Beal, et al.Nature Communications|October 27, 2022
Targeting vasoactive intestinal peptide-mediated signaling enhances response to immune checkpoint therapy in pancreatic ductal adenocarcinomaSruthi Ravindranathan, Tenzin Passang, Jian-Ming Li, et al.Surgical Oncology|September 6, 2020
A closer look at the natural history and recurrence patterns of high-grade truncal/extremity leiomyosarcomas: A multi-institutional analysis from the US Sarcoma CollaborativeRachel M Lee, Cecilia G Ethun, Mohammad Y Zaidi, et al.JCI Insight|March 7, 2023
Dual IL-6 and CTLA-4 blockade regresses pancreatic tumors in a T cell- and CXCR3-dependent mannerMichael Brandon Ware, Maggie Phillips, Christopher McQuinn, et al.Annals of Surgical Oncology|May 8, 2020
The Intersection of Age and Tumor Biology with Postoperative Outcomes in Patients After Cytoreductive Surgery and HIPECMichael K Turgeon, Adriana C Gamboa, Rachel M Lee, et al.Journal of Surgical Oncology|December 5, 2022
Influence of insurance status on the postoperative outcomes of cytoreductive surgery and HIPECBoateng Kubi, Richard Nudotor, Nadege Fackche, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 10, 2021
Prognostic Significance of Preoperative Tumor Markers in Pseudomyxoma Peritonei from Low-Grade Appendiceal Mucinous Neoplasm: a Study from the US HIPEC CollaborativeWasay Nizam, Nadege Fackche, Bernardo Pessoa, et al.Cancer Research|December 19, 2025
High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Features in Primary and Metastatic Pancreatic Ductal AdenocarcinomaEmily Greene, Natalie K Horvat, Deon Bryant Doxie, et al.Annals of Surgical Oncology|February 3, 2024
Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: An Analysis from the US HIPEC CollaborativeNadege T Fackche, Ryan K Schmocker, Richard Nudotor, et al.Annals of Surgical Oncology|August 4, 2026
Secondary Cytoreductive Surgery ± Hyperthermic Intraperitoneal Chemotherapy for Recurrent Colorectal Cancer Peritoneal MetastasesKailey M Oppat, Frances J Bennett, Sameer H Patel, et al.Pageof 15